ADAditxt, Inc. ADTX · OTC
$0.00 -33.33% (-$0.00)
- Market cap
- $598.8K
- Enterprise value
- $4.56M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 41.8x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -406.3%
- Bruto marža
- 19.9%
- Neto marža
- -362,386.0%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.93
- Free float
- 0.0%
O podjetju
Aditxt, Inc. (ADTX) is a biotechnology company specializing in the development of innovative therapeutic and diagnostic technologies in the fields of immunology and biomedicine. The company focuses on developing products that can enhance patients' immune systems and improve their health. Aditxt develops diagnostic tools that allow for precise monitoring of immune responses and patients' health status. With the growing emphasis on personalized medicine and advanced diagnostic technologies, Aditxt, Inc. has the potential for sustained growth. Aditxt, Inc. (ADTX) shares might be an interesting choice for investors seeking involvement in the biotechnology and innovative diagnostic therapies industry.
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey Busch
Employees
26
Headquarters
Mountain View
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke